AUPH

Aurinia Pharmaceuticals Inc
Data: 2026-07-02
$15.61
Price
-1.20%
Change
$19.25
52W High
$7.29
52W Low

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Quick Stats
Jul 02, 2026

54.8

AI Score

HOLD

1.6

Volume Ratio

Jul 30, 2026

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

AUPH Stock Summary

Last updated Jul 02, 2026

AUPH is currently trading at $15.61, positioned above its 200-day moving average of $14.79, indicating a long-term uptrend. The stock has a 52-week range of $7.285 to $19.25.

Technical Analysis: The 50-day moving average stands at $15.99, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 42.978, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.155, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates AUPH at 54.8/100 with a HOLD recommendation.

AUPH (Aurinia Pharmaceuticals Inc) Indicators

Last updated Jul 02, 2026

Indicator Value
RSI(14) 42.978
CMF (20) -0.155
ROC (10) -3.284
ADX (14) 26.149
Indicator Value
MACD (12,26,9) 0.206
AROONOSC (14) -42.857
WILLAMS %R (14) -89.655
MFI (14) 47.175
AUPH Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

AUPH Price vs Max Options Open Interest
AUPH Max Change In Options Open Interest

AUPH Options - Sort by Max open Interest (near term)

6th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

AUPH Daily Out of Money Options - Sort by Max open Interest (near term)

6th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

AUPH Daily In the Money Options - Sort by Max open Interest (near term)

6th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

AUPH Most Active Options by Volume(near term)

6th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Aurinia Pharmaceuticals Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

AUPH Moving Averages Analysis

Aurinia Pharmaceuticals Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 02, 2026

AUPH (Aurinia Pharmaceuticals Inc) Simple Moving Averages

Moving Averages are last updated Jul 02, 2026

Days MA
10 17.04
20 16.49
30 16.14
50 15.99
100 15.4
200 14.79

AUPH Fundamental Analysis

P/E (Forward) 18.3486
P/E (Trailing) 7.3148
Market Cap ($) 2.0 billion
Earnings/Share ($) 2.16
Net Proft Margin (%) 0.9997
Dividend/Share ($) --
EPS Estimate Current Year ($) 0.96
EPS Estimate Next Year ($) 1.118
WallStreet Target Price ($) 17
Most Recent Quarter